Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNA damage induced by beta radiation is a consequence of exposure of cellular DNA to beta particles, a form of ionizing radiation. This process primarily occurs through the generation of reactive oxygen species (ROS) and direct ionization events, leading to a spectrum of DNA lesions including single-strand breaks, double-strand breaks, and base modifications. The resulting DNA damage can activate multiple cellular pathways, such as cell cycle arrest, apoptosis, and the recruitment of DNA repair mechanisms like base excision repair (BER) and non-homologous end joining (NHEJ). Such damage is an important component of the mechanism of action for beta-emitting radiotherapeutics in oncology but also underlies the risk of genomic instability and tissue toxicity in off-target cells.
Generation of **reactive oxygen species (ROS)** leading to indirect DNA damage (single-strand breaks, double-strand breaks, base modifications) Direct ionization and bond disruption in DNA, causing strand breaks and base/sugar modifications
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA damage induced by beta radiation.